Breaking News

You are here » Indian-Commodity  :  Commodities  :  Chana  :  Chana futures trade lower on NCDEX

02-Aug2014

Chana futures trade lower on NCDEX

Chana futures declined on NCDEX as an increase in the sowing of kharif pulses coupled with revival of monsoon rainfed areas of western India where the crop is grown. Further, sluggish demand from dal mills in the spot market too added pressure on chana prices.

The contract for August delivery was trading at Rs 2805.00, down by 0.07% or Rs 2.00 from its previous closing of Rs 2807.00. The open interest of the contract stood at 90330 lots.

The contract for September delivery was trading at Rs 2891.00, down by 0.31% or Rs 9.00 from its previous closing of Rs 2900.00. The open interest of the contract stood at 114680 lots on NCDEX.

 


Related News

View all news

Government imposes 30% import duty on Chana, Masoor

Government has decided to impose 30% import duty on Chana (Chickpeas) and Masoor (Lentils), with immediate effect. The production of Chana (Chickpeas) and Masoor (Lentils) are expected to be high during......

NCDEX reports Rs 91 crore turnover in chana contract on re-launch day

National Commodity & Derivatives Exchange (NCDEX), an online agri-commodity exchange has registered a turnover of Rs 91 crore on the first day of the re-launch of chana (pulses) contracts. The......

NCDEX receives SEBI's nod to re-launch chana futures

National Commodity & Derivatives Exchange (NCDEX), an online agri-commodity exchange will re-launch the chana futures contract expiring in the months of September 2017, October 2017 and November......

Top News

View all news

RPP Infra Projects bags orders worth Rs 62.90 crore from BHEL

RPP Infra Projects has bagged orders from Bharat Heavy Electricals (BHEL), Chennai for worth of Rs 62.90 crore. The first order is for providing civil works of Boiler, Mill and Bunker, ESP area of unit......

Glenmark gets tentative ANDA approval for Abiraterone Acetate Tablets

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate Tablets USP, 250 mg, a generic......

HDFC Standard Life Insurance reports 18% rise in Q3 net profit

HDFC Standard Life Insurance has reported results for third quarter ended December 31, 2018. The company has reported a rise of 18.48% in its net profit at Rs 245.63 crore for the quarter under review......